| Financial Year |
March 31 2023 |
| Monetary Funds |
670,923,227.62 |
| Held-for-trading Financial Assets |
67,296,986.30 |
| Notes Receivable |
32,901,271.84 |
| Accounts Receivable |
218,851,268.81 |
| Advances to Suppliers |
17,345,386.38 |
| Other Receivables |
15,610,862.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
427,654,334.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,954,040.72 |
| Total Current Assets |
1,519,931,470.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
245,795,718.37 |
| Investment Properties |
14,153,192.34 |
| Fixed Assetes |
511,051,571.22 |
| Under-construction Projects |
69,369,544.96 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
106,713,630.85 |
| R&D expenses |
-- |
| Goodwill |
323,998,277.56 |
| Long-Term Deferred and Prepaid Expenses |
4,344,594.47 |
| Deferred Income Tax Assets |
35,872,300.88 |
| Other Non-Current Assets |
13,342,685.00 |
| Sub-Total of Non-Current Assets |
1,381,100,763.56 |
| Total Assets |
2,901,032,233.82 |
| Short-Term Loans |
94,046,255.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
144,728,318.00 |
| Accounts Payable |
223,484,300.63 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
22,360,868.01 |
| Taxes Payable |
20,755,741.55 |
| Interest Payable |
-- |
| Dividend Payable |
280,786.52 |
| Other payables |
310,046,164.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
25,561,758.10 |
| Other Current Liabilities |
3,237,913.82 |
| Sub-Total of Current Liabilities |
859,186,397.24 |
| Long-term Loans |
192,050,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,630,707.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
227,981,975.96 |
| Total Liabilities |
1,087,168,373.20 |
| Paid-In Capital(Or Share Stock) |
139,122,887.00 |
| Capital Surplus |
784,722,356.78 |
| Surplus Reserve |
58,202,265.07 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
566,740,307.48 |
| Minority Stockholder's Interest |
260,455,461.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,553,408,399.01 |
| Owner's Equity（Stockholder's Equity） |
1,813,863,860.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,901,032,233.82 |
